A B Gottlieb, A Deodhar, I B Mcinnes, X Baraliakos, K Reich, S Schreiber, W Bao, K Marfo, H B Richards, L Pricop, A Shete, V Trivedi, D Keefe, C C Papavassilis, P Jagiello, P Papanastasiou, P J Mease, M Lebwohl
Issues - Maggio 2022
A B Gottlieb, A Deodhar, I B Mcinnes, X Baraliakos, K Reich, S Schreiber, W Bao, K Marfo, H B Richards, L Pricop, A Shete, V Trivedi, D Keefe, C C Papavassilis, P Jagiello, P Papanastasiou, P J Mease, M Lebwohl
K Reich, D Thaçi, G Stingl, J S Andersen, L C Hiort, M O Lexner, D Winkler, C Paul
Safety of brodalumab in plaque psoriasis: Integrated pooled data from five clinical trials
Acta Derm Venereol. 2022 Mar 28;102:adv00683V Viswanath, P Joshi, P Lawate, D Tare, D Dhoot, N Mahadkar, H Barkate
An open-label, randomized, prospective, comparative, three-arm clinical trial to evaluate the safety and effectiveness of apremilast with three different titration methods in patients with chronic plaque psoriasis in India
Psoriasis (Auckl). 2022 Apr 22;12:53-61Z D Draelos
The efficacy and tolerability of turmeric and salicylic acid in psoriasis treatment
Psoriasis (Auckl). 2022 Apr 29;12:63-71S Löfvendahl, J M Norlin, M Schmitt-Egenolf
Economic burden of generalized pustular psoriasis in sweden: A population-based register study
Psoriasis (Auckl). 2022;12:89-98K Xue, S Shao, H Fang, L Ma, C Li, Z Lu, G Wang
Adipocyte-derived CTRP3 exhibits anti-inflammatory effects via lamp1-stat3 axis in psoriasis
J Invest Dermatol. 2022 May;142(5):1349-1359.e8T Khosravi-Hafshejani, M Ghoreishi, C V Kellet, R I Crawford, M Martinka, J P Dutz
Small plaque psoriasis re-visited: A type of psoriasis mediated by a type-I interferon pathway
Exp Dermatol. 2022 May;31(5):753-763F Bellinato, G Adami, S Vaienti, C Benini, D Gatti, L Idolazzi, A Fassio, M Rossini, G Girolomoni, P Gisondi
Association between short-term exposure to environmental air pollution and psoriasis flare
JAMA Dermatol. 2022 Apr 1;158(4):375-381C Xu, A Teeple, B Wu, T Fitzgerald, S R Feldman
Drug adherence and persistence of patients with moderate to severe psoriasis treated with biologic medications in a us commercially insured population
Dermatology. 2022;238(3):438-447J H Han, J W Park, K D Han, J B Park, M Kim, J H Lee
Smoking and periodontitis can play a synergistic role in the development of psoriasis: A nationwide cohort study
Dermatology. 2022;238(3):554-561H J Lee, K Han, H Soh, S-J Koh, J P Im, J S Kim, H E Park, M Kim
Occult blood in feces is associated with increased risk of psoriasis
Dermatology. 2022;238(3):571-578K Papp, C Paul, C E Kleyn, Y-H Huang, T-F Tsai, C Schuster, C El Baou, A Toth, E Riedl, U Mrowietz
Time to loss of response following withdrawal of ixekizumab in patients with moderate-to-severe psoriasis
Acta Derm Venereol. 2022 Mar 15;102:adv00672A Blauvelt, N Shi, M Murage, T Ridenour, C Lew, N Somani, B Zhu, N Zimmerman, S Kern, R Burge